Data as of Mar 14
| -0.21 / -0.61%|
The 14 analysts offering 12-month price forecasts for Thoratec Corp have a median target of 45.00, with a high estimate of 49.00 and a low estimate of 37.00. The median estimate represents a +31.62% increase from the last price of 34.19.
The current consensus among 16 polled investment analysts is to Buy stock in Thoratec Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.